2013 American Transplant Congress
In Vivo IL-2 Administration Can Abrogate Tolerance to Kidney Allografts Induced Via Mixed Chimerism in Non-Human Primates
Transplant Center, Massachusetts General Hospital, Boston, MA
We previously reported successful induction of renal allograft tolerance in nonhuman primates and humans by the mixed chimerism approach. Different from rodent studies, chimerism induced…2013 American Transplant Congress
HLA-DQ Mismatch Is an Independent Predictor of De Novo Donor-Specific HLA Antibodies after Liver Transplantation
Aim: Patients who develop de novo donor-specific HLA antibodies (DSA) may have an increased risk of patient death and graft loss. We seek to examine…2013 American Transplant Congress
Prolonged Cold Ischemia Impairs Outcome in Recipients of DCD Kidney Transplants, Despite Machine Perfusion
Introduction: The impact of prolonged cold ischemia time (CIT) on kidney grafts donated after circulatory death (DCD) remains unclear when grafts were preserved by hypothermic…2013 American Transplant Congress
Outcome in Patients Undergoing HeartMate II vs HVAD Left Ventricular Assist Device (LVAD) Implantation as a Bridge to Transplantation in Middle Aged Patients – A Single Center Experience
Objective The HeartMate II (HM II) and the HVAD are routinely used as LVADs. The aim of this study was to compare the two devices…2013 American Transplant Congress
Excellent Liver Transplant Outcomes in Patients with Coronary Artery Disease
Aim: The aim of this study is to assess the risk factors for coronary artery disease (CAD) in patients undergoing orthotopic liver transplantation (OLT), and…2013 American Transplant Congress
Presence of Circulating Antibodies at the Time of Pathology Defined Antibody-Mediated Rejection after Heart Transplant: Are They out There?, The
Cedars-Sinai Heart Institute, Los Angeles, CA
BACKGROUND: The diagnosis of antibody mediated rejection (AMR) is standardized based on the ISHLT pAMR grading scale which stratifies biopsies based on the presence or…2013 American Transplant Congress
Pathology and Clinical Progression of Biopsy Proven pAMR1 after Heart Transplantation
Cedars-Sinai Heart Institute, Los Angeles, CA
BACKGROUND: Antibody mediated rejection has now been defined as a pathology definition. The new ISHLT pathology grading scale was recently published by Barry et al.…2013 American Transplant Congress
Intraoperative Renal Replacement Therapy during Liver Transplant: Outcomes of 105 Cases
Renal dysfunction in liver transplant (LT) candidates increases intraoperative risks. One year survival in patients requiring pre or post operative renal replacement therapy (RRT) is…2013 American Transplant Congress
Pre-Transplant Cardiovascular Risk Factors Improve the SRTR Cox Proportional Hazard Model for 1 Year Patient Survival after Deceased Donor Kidney Transplant
Surgery/Transplantation, The Ohio State University Wexner Medical Center, Columbus, OH
Background:Debate continues regarding the utility of including additional clinical variables to improve SRTR center-specific predicted outcomes. In this study we used a cohort of kidney…2013 American Transplant Congress
Durability of Pancreatic Islets Transplantation in Brittle Type 1 Diabetics – 9 Year Follow Up
The aim of the study was to assess long-term outcomes of the pancreatic islet transplantation. Methods: Human pancreatic islets were administered sequentially in up to…
American Transplant Congress abstracts